An Area of Significant Unmet Medical Need
Infectious diseases of the genitourinary system compromise quality of life for many women and can lead to serious conditions including pelvic inflammatory disease, infertility and cervical cancer. Women commonly experience genitourinary system infections:
There is a substantial need for novel therapeutics for infectious diseases of the genitourinary system. A variety of bacterial and viral pathogens, fungi and protozoan may cause infections of the reproductive system. Multi-drug resistant bacterial and protozoan STIs and HIV are significant global issues. In the treatment of UTIs, antimicrobial resistance is a challenge. Additionally, existing antivirals are not recommended for human papillomavirus (HPV) infections; therapeutics are primarily ablative or immunomodulatory. Clinical research is necessary to offer alternative treatment options and improve health outcomes in patients experiencing genitourinary system infections.